(Q35055001)

6 August 2017

1 reference

title

Animal and human models for sepsis (English)

1 reference

6 August 2017

0 references

2

Tom van der Poll

1 reference

6 August 2017

Marc J Schultz

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

6 August 2017

1 reference

6 August 2017

volume

34

1 reference

6 August 2017

issue

7-8

1 reference

6 August 2017

page(s)

573-581

1 reference

Anti-inflammatory therapies in sepsis and septic shock

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

21 January 2018

Immunotherapy of sepsis

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Sepsis and septic shock--a review of laboratory models and a proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Laboratory models of sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Mechanism of immunosuppression in males following trauma-hemorrhage. Critical role of testosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Distribution of polysaccharide side chains of lipopolysaccharide determine resistance of Escherichia coli to the bactericidal activity of serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Cytokines and anticytokines in the pathogenesis of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Role of cytokines in pulmonary antimicrobial host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Animal models of sepsis and shock: a review and lessons learned.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Interleukin-10 impairs host defense in murine pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902321117797

10.1080/078538902321117797

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference